Article info

Download PDFPDF
Loss of MSH2 protein expression is a risk factor in early stage cervical cancer
  1. Correspondence to:
 Dr A G J van der Zee
 Department of Gynaecologic Oncology, University Medical Centre Groningen, PO Box 30.001, 9700 RB Groningen, the Netherlands; a.g.j.van.der.zee{at}og.umcg.nl
View Full Text

Citation

Nijhuis ER, Nijman HW, Oien KA, et al
Loss of MSH2 protein expression is a risk factor in early stage cervical cancer

Publication history

  • Accepted July 26, 2006
  • First published June 27, 2007.
Online issue publication 
October 25, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.